Hormonal therapy

Some breast cancers are caused due to the hormones in blood. It is a form of systemic therapy it not only reaches the cancer cells present in breast also reaches cancer cells all over the body. Hormonal therapy is recommended for women with hormone receptor-positive breast cancers, it is not useful for the women who are suffering with hormone receptor-negative breast cancer.

Hormonal therapy is often used as adjuvant therapy to reduce the risk of cancer coming back. Sometimes this therapy is started as neoadjuvant therapy. The drugs that stop estrogen from affecting breast cancer cells are,

  • ER-positive cancers
  • PR-positive cancers
  • Adjuvant therapy
  • Neo-adjuvant therapy
  • Breast cancer hormone therapy
  • Prostate cancer hormone therapy
  • Womb cancer hormone therapy

Related Conference of Hormonal therapy

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Hormonal therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in